Medifast, Inc. (LON:0K05)
London flag London · Delayed Price · Currency is GBP · Price in USD
10.70
-0.33 (-2.95%)
At close: Feb 12, 2026

Medifast Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
821505691,0401,7901,685
Market Cap Growth
-40.42%-73.64%-45.32%-41.90%6.23%76.12%
Enterprise Value
-36284621,0051,6871,570
Last Close Price
7.9314.1652.6289.13139.86128.17
PE Ratio
442.9789.767.298.7314.7822.37
PS Ratio
0.260.310.680.781.592.46
PB Ratio
0.510.893.608.0811.9714.63
P/TBV Ratio
0.510.893.608.0811.9714.63
P/FCF Ratio
170.0611.035.137.0540.1716.52
P/OCF Ratio
15.277.674.916.4425.6415.85
EV/Sales Ratio
-0.060.550.761.502.29
EV/EBITDA Ratio
-1.264.226.1910.2415.48
EV/EBIT Ratio
-2.304.666.5510.5615.97
EV/FCF Ratio
-75.862.084.176.8137.8515.38
Debt / Equity Ratio
0.060.080.110.170.160.07
Debt / EBITDA Ratio
0.480.490.150.130.140.08
Debt / FCF Ratio
18.980.950.160.150.540.08
Net Debt / Equity Ratio
-0.75-0.70-0.63-0.40-0.38-1.04
Net Debt / EBITDA Ratio
-7.77-5.21-0.92-0.31-0.34-1.18
Net Debt / FCF Ratio
-249.61-8.59-0.91-0.35-1.28-1.17
Asset Turnover
1.542.033.424.474.533.97
Inventory Turnover
3.743.253.423.073.414.64
Quick Ratio
3.712.531.630.620.651.57
Current Ratio
4.453.342.431.581.812.10
Return on Equity (ROE)
0.12%1.02%55.77%80.31%91.20%78.50%
Return on Assets (ROA)
1.52%3.24%25.24%32.33%40.08%35.63%
Return on Invested Capital (ROIC)
1.40%12.37%116.95%131.72%274.89%1044.12%
Return on Capital Employed (ROCE)
3.10%7.00%58.10%105.40%94.60%81.40%
Earnings Yield
0.23%1.11%13.72%11.46%6.77%4.47%
FCF Yield
0.59%9.07%19.49%14.19%2.49%6.05%
Dividend Yield
--7.38%6.11%3.00%2.58%
Payout Ratio
78.63%34.19%73.45%49.89%38.93%51.71%
Buyback Yield / Dilution
-0.27%-0.39%3.15%4.55%0.31%2.20%
Total Shareholder Return
-0.27%-0.39%10.53%10.66%3.31%4.79%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.